| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2006PNAS..103.7450N |
| P356 | DOI | 10.1073/PNAS.0602259103 |
| P932 | PMC publication ID | 1464359 |
| P698 | PubMed publication ID | 16651522 |
| P5875 | ResearchGate publication ID | 7129065 |
| P50 | author | Antti Vaheri | Q11852265 |
| Maria Söderlund-Venermo | Q40817203 | ||
| Klaus Hedman | Q42901953 | ||
| P2093 | author name string | Hans-Peter Fischer | |
| Olli Vapalahti | |||
| Annamari Ranki | |||
| Anna Maria Eis-Hübinger | |||
| Leena-Maija Aaltonen | |||
| Kati Hokynar | |||
| Renwei Chen | |||
| Irja Davidkin | |||
| Beate Schneider | |||
| Esa K Partio | |||
| René Tolba | |||
| Olli Kiviluoto | |||
| Päivi Norja | |||
| Tomi Leivo | |||
| P2860 | cites work | Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry | Q44542238 |
| Risk of human parvovirus B19 infections among school and hospital employees during endemic periods | Q45091966 | ||
| Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization | Q45659478 | ||
| Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue | Q45743695 | ||
| Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study | Q47193572 | ||
| Sequence variability among different parvovirus B19 isolates | Q48061770 | ||
| Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. | Q48164325 | ||
| Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. | Q50762695 | ||
| Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR). | Q53315230 | ||
| Slow clearance of human parvovirus B19 viremia following acute infection | Q59315598 | ||
| No association between human parvovirus B19 and testicular germ cell cancer | Q59315616 | ||
| Human parvovirus B19 infection during pregnancy – Value of modern molecular and serological diagnostics | Q61865937 | ||
| Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children | Q64381824 | ||
| Replication of the B19 parvovirus in human bone marrow cell cultures | Q69580453 | ||
| Human parvovirus (B19) and erythema infectiosum | Q70090512 | ||
| Parvovirus B19 Clearance from Peripheral Blood after Acute Infection | Q71829719 | ||
| Parvovirus B19 DNA is frequently present in recombinant coagulation factor VIII products | Q71912358 | ||
| Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity | Q72592803 | ||
| Microbial DNA in the synovium--a role in aetiology or a mere bystander? | Q73233269 | ||
| Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy | Q73233286 | ||
| Evidence for persistence of human parvovirus B19 DNA in bone marrow | Q73870588 | ||
| Evidence for persistence of parvovirus B19 DNA in livers of adults | Q74460725 | ||
| Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2 | Q80828034 | ||
| Cloning of a human parvovirus by molecular screening of respiratory tract samples | Q24531941 | ||
| High rate of viral evolution associated with the emergence of carnivore parvovirus | Q24557529 | ||
| New DNA viruses identified in patients with acute viral infection syndrome. | Q27469839 | ||
| The structure of human parvovirus B19 | Q30163895 | ||
| Primary and secondary infections by human parvovirus B19 following bone marrow transplantation: characterization by PCR and B-cell molecular immunology | Q33499482 | ||
| Novel human erythrovirus associated with transient aplastic anemia. | Q33961922 | ||
| Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells | Q34124006 | ||
| Prevalence of Parvovirus B19 in Liver Tissue: No Association with Fulminant Hepatitis or Hepatitis‐Associated Aplastic Anemia | Q34193789 | ||
| Genetic diversity within human erythroviruses: identification of three genotypes. | Q34344907 | ||
| Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms | Q34430679 | ||
| Retrospective birth dating of cells in humans | Q34432993 | ||
| High mutant frequency in populations of a DNA virus allows evasion from antibody therapy in an immunodeficient host | Q34472287 | ||
| High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. | Q34554896 | ||
| Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic | Q34569072 | ||
| Persistence of human parvovirus B19 in human tissues | Q34737815 | ||
| Human parvovirus B19 as a causative agent for rheumatoid arthritis | Q36173035 | ||
| Identification and characterization of persistent human erythrovirus infection in blood donor samples | Q37596753 | ||
| Epidemiology of Sindbis virus infections in Finland 1981-96: possible factors explaining a peculiar disease pattern. | Q39123995 | ||
| Prokaryotic expression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay | Q40185215 | ||
| Human parvovirus B19 infection of monocytic cell line U937 and antibody-dependent enhancement | Q40358470 | ||
| Parvovirus B19-induced apoptosis of hepatocytes | Q40541084 | ||
| A new parvovirus genotype persistent in human skin | Q40688832 | ||
| Identification and characterization of a second novel human erythrovirus variant, A6. | Q40700242 | ||
| Rapid diagnosis of hantavirus disease with an IgG-avidity assay | Q40742587 | ||
| Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests | Q40834278 | ||
| Identification of a novel RNA splicing pattern as a basis of restricted cell tropism of erythrovirus B19. | Q40858121 | ||
| Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue | Q42721936 | ||
| Characteristics and taxonomy of Parvoviridae | Q43864399 | ||
| Cloning of the human parvovirus B19 genome and structural analysis of its palindromic termini | Q43879314 | ||
| Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma | Q44238193 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 4 | |
| P304 | page(s) | 7450-7453 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue | |
| P478 | volume | 103 |
| Q39369050 | A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression. |
| Q39353606 | A new protoparvovirus in human fecal samples and cutaneous T cell lymphomas (mycosis fungoides). |
| Q34900621 | A newly identified bocavirus species in human stool |
| Q34120947 | Advances in human B19 erythrovirus biology |
| Q92026959 | Advances in the Development of Antiviral Strategies against Parvovirus B19 |
| Q37410780 | Analysis of nucleotide sequences of human parvovirus B19 genome reveals two different modes of evolution, a gradual alteration and a sudden replacement: a retrospective study in Sapporo, Japan, from 1980 to 2008. |
| Q56965812 | Ancient human parvovirus B19 in Eurasia reveals its long-term association with humans |
| Q41868019 | Biological and immunological relations among human parvovirus B19 genotypes 1 to 3. |
| Q36324310 | Bones hold the key to DNA virus history and epidemiology |
| Q93161981 | Carnivore Parvovirus Ecology in the Serengeti Ecosystem: Vaccine Strains Circulating and New Host Species Identified |
| Q35804598 | Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa. |
| Q27468863 | Chlamydia-Like Organisms (CLOs) in Finnish Ixodes ricinus Ticks and Human Skin |
| Q47606050 | Clinical significance of parvovirus B19 DNA in cutaneous biopsies |
| Q34941558 | Co-infection of human parvovirus B19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patients |
| Q59357167 | Coinfections identified from metagenomic analysis of cervical lymph nodes from tularemia patients |
| Q35888909 | Comparative analysis reveals frequent recombination in the parvoviruses |
| Q48223107 | Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. |
| Q35781991 | Detection of human parvovirus 4 viremia in the follow-up blood samples from seropositive individuals suggests the existence of persistent viral replication or reactivation of latent viral infection. |
| Q40333639 | Detection of human parvovirus B19 DNA in 22% of 1815 cutaneous biopsies of a wide variety of dermatological conditions suggests viral persistence after primary infection and casts doubts on its pathogenic significance. |
| Q33315775 | Detection of human parvovirus B19 in papillary thyroid carcinoma |
| Q54335776 | Detection of parvovirus B19 capsid proteins in testicular tissues. |
| Q54471985 | Detection of parvovirus B19 in the lower respiratory tract. |
| Q38088715 | Diagnosis of in utero Parvovirus B19 infection and maternal immune response - the relevance of linear epitopes and advanced serologic testing |
| Q43985866 | Different patterns of disease manifestations of parvovirus B19-associated reactive juvenile arthritis and the induction of antiphospholipid-antibodies |
| Q34043407 | Discovery and genomic characterization of a novel ovine partetravirus and a new genotype of bovine partetravirus |
| Q36665779 | Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors |
| Q47548065 | Endogenous Retrovirus 3 - History, Physiology, and Pathology |
| Q90643417 | Equine Parvovirus-Hepatitis in China: Characterization of Its Genetic Diversity and Evidence for Natural Recombination Events Between the Chinese and American Strains |
| Q33538033 | Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection: molecular characteristics and functional competence |
| Q37263290 | Existence of various human parvovirus B19 genotypes in Chinese plasma pools: genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes |
| Q40259414 | Extinct type of human parvovirus B19 persists in tonsillar B cells |
| Q38373801 | Feline Panleukopenia Virus Is Not Associated With Myocarditis or Endomyocardial Restrictive Cardiomyopathy in Cats |
| Q34503893 | Frequent cross-species transmission of parvoviruses among diverse carnivore hosts |
| Q38432271 | Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals |
| Q51878056 | Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation. |
| Q37946371 | From orphan virus to pathogen: the path to the clinical lab. |
| Q36422933 | Genetic characterization of parvoviruses circulating in turkey and chicken flocks in Poland |
| Q43807942 | Genetic diversity of human erythroviruses. Consequences on infectious safety of plasma derivatives |
| Q33614182 | Genetic variants of human parvovirus B19 in South Africa: cocirculation of three genotypes and identification of a novel subtype of genotype 1 |
| Q39644951 | Genomic features of the human bocaviruses |
| Q39718255 | Genotype-specific effects on left ventricular function in parvovirus B19-positive patients with dilated cardiomyopathy |
| Q55686767 | Genotypes of erythrovirus B19, their geographical distribution & circulation in cases with various clinical manifestations. |
| Q40655396 | Granzyme B mediated function of Parvovirus B19-specific CD4(+) T cells |
| Q37436158 | Heterogeneous pathways of maternal-fetal transmission of human viruses (review). |
| Q34039466 | High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies |
| Q34833986 | High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. |
| Q37051449 | High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy |
| Q93117453 | High-Throughput Sequencing-Based Investigation of Viruses in Human Cancers by Multienrichment Approach |
| Q38996997 | Human Parvoviruses |
| Q40433723 | Human bocavirus in children with acute lymphoblastic leukemia. |
| Q37950974 | Human bocavirus-the first 5 years |
| Q34660084 | Human erythrovirus B19 and blood transfusion - an update |
| Q36393530 | Human immunodeficiency virus/human parvovirus B19 co-infection in blood donors and AIDS patients in Sichuan, China |
| Q30238496 | Human parvovirus 4 'PARV4' remains elusive despite a decade of study |
| Q43146818 | Human parvovirus 4 in the blood supply and transmission by pooled plasma-derived clotting factors: does it matter? |
| Q51874195 | Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT. |
| Q37643489 | Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study |
| Q93054615 | Immunosuppression in inflammatory cardiomyopathy and parvovirus B19 persistence |
| Q50500602 | Impact of chemiluminescent enzyme immunoassay screening for human parvovirus B19 antigen in Japanese blood donors. |
| Q44659453 | Inactivation and neutralization of parvovirus B19 Genotype 3. |
| Q38394102 | Infection and persistence of erythrovirus B19 in benign and cancerous thyroid tissues |
| Q40021578 | Insights into epidemiology of human parvovirus B19 and detection of an unusual genotype 2 variant, Bulgaria, 2004 to 2013. |
| Q37470424 | Keeping pace with parvovirus B19 genetic variability: a multiplex genotype-specific quantitative PCR assay. |
| Q30318661 | Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury. |
| Q43505496 | Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: implications for respiratory transmission and latency |
| Q37465311 | Molecular characterization of human parvovirus B19 genotypes 2 and 3. |
| Q37722777 | Molecular phenotypes of human parvovirus B19 in patients with myocarditis |
| Q33614681 | Multiple diverse circoviruses infect farm animals and are commonly found in human and chimpanzee feces |
| Q34618009 | Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure |
| Q33340287 | NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy |
| Q90712228 | Newly detected DNA viruses in juvenile nasopharyngeal angiofibroma (JNA) and oral and oropharyngeal squamous cell carcinoma (OSCC/OPSCC) |
| Q35877101 | Novel human parvovirus 4 genotype 3 in infants, Ghana |
| Q54304445 | Occurrence of human bocaviruses and parvovirus 4 in solid tissues. |
| Q33800906 | Parenteral transmission of the novel human parvovirus PARV4. |
| Q34625443 | Parvovirus B19 - Revised |
| Q58666387 | Parvovirus B19 Achievements and Challenges |
| Q48077693 | Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays |
| Q49416500 | Parvovirus B19: What Is the Relevance in Transfusion Medicine? |
| Q35066936 | Parvovirus among patients with cytopenia of unknown origin in Brazil: a case-control study |
| Q34193790 | Parvovirus b19 DNA CpG dinucleotide methylation and epigenetic regulation of viral expression |
| Q42229102 | Parvovirus b19 persistence in abnormal thyroid tissue of a mature cystic ovarian teratoma: a case report |
| Q30571511 | Parvovirus transmission by blood products - a cause for concern? |
| Q43071556 | Parvoviruses PARV4/5 in hepatitis C virus-infected patient |
| Q35185105 | Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors |
| Q45383001 | Persistent adeno-associated virus 2 and parvovirus B19 sequences in post-mortem human cerebellum |
| Q38226745 | Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process |
| Q37410574 | Phylogenetic analysis of human parvovirus b19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b |
| Q40777639 | Predictors of outcome in patients with parvovirus B19 positive endomyocardial biopsy |
| Q42202200 | Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India |
| Q51905617 | Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. |
| Q36747943 | Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections |
| Q36392404 | Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis |
| Q92879788 | Systematic Review of PCR Proof of Parvovirus B19 Genomes in Endomyocardial Biopsies of Patients Presenting with Myocarditis or Dilated Cardiomyopathy |
| Q38655527 | The MOGE(S) classification for cardiomyopathies: current status and future outlook |
| Q38529622 | The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability. |
| Q53848811 | Therapeutic implications of a combined diagnostic workup including endomyocardial biopsy in an all-comer population of patients with heart failure: a retrospective analysis. |
| Q37099683 | Transmission networks and population turnover of echovirus 30 |
| Q90463911 | Tropism, pathology, and transmission of equine parvovirus-hepatitis |
| Q38700547 | Update of the human parvovirus B19 biology |
| Q43461065 | Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates |
| Q28650535 | What is for dinner? Viral metagenomics of US store bought beef, pork, and chicken |
| Q34120900 | Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild |
| Q52887298 | miRNA as activity markers in Parvo B19 associated heart disease. |
Search more.